Prestige Consumer Healthcare Price to Sales Ratio 2010-2025 | PBH
Historical PS ratio values for Prestige Consumer Healthcare (PBH) over the last 10 years. The current P/S ratio for Prestige Consumer Healthcare as of July 04, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Prestige Consumer Healthcare P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-07-03 | 79.98 | 3.52 | |
| 2025-03-31 | 85.97 | $22.72 | 3.78 |
| 2024-12-31 | 78.09 | $22.32 | 3.50 |
| 2024-09-30 | 72.10 | $22.15 | 3.25 |
| 2024-06-30 | 68.85 | $22.19 | 3.10 |
| 2024-03-31 | 72.56 | $22.44 | 3.23 |
| 2023-12-31 | 61.22 | $22.65 | 2.70 |
| 2023-09-30 | 57.19 | $22.50 | 2.54 |
| 2023-06-30 | 59.43 | $22.54 | 2.64 |
| 2023-03-31 | 62.63 | $22.44 | 2.79 |
| 2022-12-31 | 62.60 | $21.96 | 2.85 |
| 2022-09-30 | 49.83 | $21.86 | 2.28 |
| 2022-06-30 | 58.80 | $21.54 | 2.73 |
| 2022-03-31 | 52.94 | $21.39 | 2.48 |
| 2021-12-31 | 60.65 | $20.84 | 2.91 |
| 2021-09-30 | 56.11 | $20.17 | 2.78 |
| 2021-06-30 | 52.10 | $19.42 | 2.68 |
| 2021-03-31 | 44.08 | $18.62 | 2.37 |
| 2020-12-31 | 34.87 | $18.84 | 1.85 |
| 2020-09-30 | 36.42 | $18.87 | 1.93 |
| 2020-06-30 | 37.56 | $18.87 | 1.99 |
| 2020-03-31 | 36.68 | $18.81 | 1.95 |
| 2019-12-31 | 40.50 | $18.53 | 2.19 |
| 2019-09-30 | 34.69 | $18.40 | 1.89 |
| 2019-06-30 | 31.68 | $18.30 | 1.73 |
| 2019-03-31 | 29.91 | $18.64 | 1.60 |
| 2018-12-31 | 30.88 | $18.79 | 1.64 |
| 2018-09-30 | 37.89 | $19.22 | 1.97 |
| 2018-06-30 | 37.90 | $19.45 | 1.95 |
| 2018-03-31 | 33.30 | $19.45 | 1.71 |
| 2017-12-31 | 43.86 | $19.18 | 2.29 |
| 2017-09-30 | 49.47 | $18.19 | 2.72 |
| 2017-06-30 | 52.15 | $17.40 | 3.00 |
| 2017-03-31 | 54.87 | $16.57 | 3.31 |
| 2016-12-31 | 51.45 | $15.97 | 3.22 |
| 2016-09-30 | 47.67 | $15.67 | 3.04 |
| 2016-06-30 | 54.71 | $15.51 | 3.53 |
| 2016-03-31 | 52.72 | $15.18 | 3.47 |
| 2015-12-31 | 50.84 | $14.88 | 3.42 |
| 2015-09-30 | 44.60 | $14.86 | 3.00 |
| 2015-06-30 | 45.66 | $14.43 | 3.16 |
| 2015-03-31 | 42.36 | $13.58 | 3.12 |
| 2014-12-31 | 34.29 | $12.70 | 2.70 |
| 2014-09-30 | 31.97 | $11.72 | 2.73 |
| 2014-06-30 | 33.47 | $11.47 | 2.92 |
| 2014-03-31 | 26.91 | $11.43 | 2.35 |
| 2013-12-31 | 35.35 | $11.63 | 3.04 |
| 2013-09-30 | 29.49 | $11.98 | 2.46 |
| 2013-06-30 | 28.53 | $11.94 | 2.39 |
| 2013-03-31 | 25.15 | $12.08 | 2.08 |
| 2012-12-31 | 19.61 | $11.79 | 1.66 |
| 2012-09-30 | 16.60 | $10.77 | 1.54 |
| 2012-06-30 | 15.48 | $9.70 | 1.60 |
| 2012-03-31 | 17.11 | $8.70 | 1.97 |
| 2011-12-31 | 11.03 | $7.98 | 1.38 |
| 2011-09-30 | 8.86 | $7.67 | 1.15 |
| 2011-06-30 | 12.57 | $7.15 | 1.76 |
| 2011-03-31 | 11.26 | $6.69 | 1.68 |
| 2010-12-31 | 11.70 | $6.12 | 1.91 |
| 2010-09-30 | 9.68 | $5.80 | 1.67 |
| 2010-06-30 | 6.93 | $5.85 | 1.19 |
| 2010-03-31 | 8.81 | $5.84 | 1.51 |
| 2009-12-31 | 7.69 | $5.65 | 1.36 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.952B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.97 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |